Comparison of the interactions of daunorubicin in a free form and attached to single-walled carbon nanotubes with model lipid membranes

Dorota Matyszewska
Beilstein J. Nanotechnol. 2016, 7, 524–532. https://doi.org/10.3762/bjnano.7.46

Supporting Information

Supporting Information File 1: DPPTE isotherms.
Format: PDF Size: 236.9 KB Download

Cite the Following Article

Comparison of the interactions of daunorubicin in a free form and attached to single-walled carbon nanotubes with model lipid membranes
Dorota Matyszewska
Beilstein J. Nanotechnol. 2016, 7, 524–532. https://doi.org/10.3762/bjnano.7.46

How to Cite

Matyszewska, D. Beilstein J. Nanotechnol. 2016, 7, 524–532. doi:10.3762/bjnano.7.46

Download Citation

Citation data can be downloaded as file using the "Download" button or used for copy/paste from the text window below.
Citation data in RIS format can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Zotero.

Presentation Graphic

Picture with graphical abstract, title and authors for social media postings and presentations.
Format: PNG Size: 411.3 KB Download

Citations to This Article

Up to 20 of the most recent references are displayed here.

Scholarly Works

  • Pourmadadi, M.; Ghaemi, A.; Shamsabadipour, A.; Rajabzadeh-Khosroshahi, M.; Shaghaghi, M.; Rahdar, A.; Pandey, S. Nanoparticles loaded with Daunorubicin as an advanced tool for cancer therapy. European journal of medicinal chemistry 2023, 258, 115547. doi:10.1016/j.ejmech.2023.115547
  • Sharma, V. K.; Stark, M.; Fridman, N.; Assaraf, Y. G.; Gross, Z. Doubly Stimulated Corrole for Organelle-Selective Antitumor Cytotoxicity. Journal of medicinal chemistry 2022, 65, 6100–6115. doi:10.1021/acs.jmedchem.1c02085
  • de Souza, M. L.; de Albuquerque Wanderley Sales, V.; Alves, L. P.; Dos Santos, W. M.; de Moura Ferraz, L. R.; de Andrade Lima, G. S.; Dos Santos Mendes, L. M.; Rolim, L. A.; Neto, P. J. R. A Systematic Review of Functionalized Polymeric Nanoparticles to Improve Intestinal Permeability of Drugs and Biological Products. Current pharmaceutical design 2022, 28, 410–426. doi:10.2174/1381612827666210804104205
  • de Souza, M. L.; de Albuquerque Wanderley Sales, V.; Alves, L. P.; Dos Santos, W. M.; de Moura Ferraz, L. R.; Lima, G.; Dos Santos Mendes, L. M.; Rolim, L. A.; Neto, P. J. R. A systematic review of functionalized polymeric nanoparticles to improve intestinal permeability of drugs and biological products. Current Pharmaceutical Design 2021, 27.
  • Stark, M.; Silva, T.; Levin, G.; Machuqueiro, M.; Assaraf, Y. G. The Lysosomotropic Activity of Hydrophobic Weak Base Drugs is Mediated via Their Intercalation into the Lysosomal Membrane. Cells 2020, 9, 1082. doi:10.3390/cells9051082
  • Matyszewska, D.; Moczulska, S. Effect of pH on the interactions of doxorubicin with charged lipid monolayers containing 1,2-dimyristoyl-sn-glycero-3-phospho-l-serine - An important component of cancer cell membranes. Electrochimica Acta 2018, 280, 229–237. doi:10.1016/j.electacta.2018.05.119
  • Matyszewska, D.; Napora, E.; Żelechowska, K.; Biernat, J. F.; Bilewicz, R. Synthesis, characterization, and interactions of single-walled carbon nanotubes modified with doxorubicin with Langmuir-Blodgett biomimetic membranes. Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology 2018, 20, 143. doi:10.1007/s11051-018-4239-x
  • Liu, S.; Song, X.-L.; Wang, Y.-H.; Wang, X.; Xiao, Y.; Wang, X.; Cheng, L.; Li, X.-T. The efficacy of WGA modified daunorubicin anti-resistant liposomes in treatment of drug-resistant MCF-7 breast cancer. Journal of drug targeting 2017, 25, 541–553. doi:10.1080/1061186x.2017.1298602
  • Suk, V. R. E.; Misran, M. Development and Characterization of DOPEPEG2000 Coated Oleic Acid Liposomes Encapsulating Anticancer Drugs. Journal of Surfactants and Detergents 2016, 20, 321–329. doi:10.1007/s11743-016-1914-8
Other Beilstein-Institut Open Science Activities